MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Anaplastic Large Cell Lymphoma

Condition 101

What is the definition of Anaplastic Large Cell Lymphoma?

Anaplastic large cell lymphoma (ALCL) is a rare type of Non-Hodgkins lymphoma. Lymphoma is a cancer of the lymph system, part of our immune system. Non-Hodgkins lymphoma involves abnormal growth of white blood cells, either T cells or B cells. Anaplastic large cell lymphoma is an aggressive cancer t ...

For more information, visit GARD

What are the alternative names for Anaplastic Large Cell Lymphoma?

  • ALCL
Learn More About This Condition

Top Global Doctors

View All Doctors

Latest Research

Latest Advance
Study
  • Condition: Newly Diagnosed Peripheral T Cell Lymphoma
  • Journal: Genome medicine
  • Treatment Used: CEOP/IVE/GDP (CEOP, cyclophosphamide, epirubicin, vincristine and prednisone) Alternating Regimen Versus CEOP
  • Number of Patients: 106
  • Published —
The purpose of the study was to compare the effectiveness and safety of CEOP/IVE/GDP (CEOP, cyclophosphamide, epirubicin, vincristine and prednisone) Alternating Regimen Versus CEOP for the treatment of newly diagnosed peripheral T-cell lymphoma.
Latest Advance
Study
  • Condition: Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly
  • Journal: International journal of environmental research and public health
  • Treatment Used: Sport Activity Training
  • Number of Patients: 0
  • Published —
This article discusses primary cutaneous anaplastic large cell lymphoma (pcALCL) in the elderly and the importance of sport activity training.
Latest Advance
Study
  • Condition: Solitary or Localized Primary Cutaneous Anaplastic Large Cell Lymphoma (PCALCL)
  • Journal: Acta dermato-venereologica
  • Treatment Used: Low-Dose Methotrexate (MTX)
  • Number of Patients: 7
  • Published —
This study investigated the effectiveness and clinical outcome of treatment with low-dose methotrexate (MTX), clinical and long-term follow-up data of patients with solitary or localized primary cutaneous anaplastic large cell lymphoma (PCALCL).
Latest Advance
Study
  • Condition: Systemic Anaplastic Large Cell Lymphoma
  • Journal: Bone marrow transplantation
  • Treatment Used: Allogeneic Stem Cell Transplantation (allo-HCT)
  • Number of Patients: 44
  • Published —
In this study, researchers evaluated the effects of undergoing allogeneic stem cell transplantation (allo-HCT) for the treatment of systemic anaplastic large cell lymphoma.
View All Latest Research

Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: July 18, 2020
Bispecific Antibody AFM13 Combined With NK Cells for Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 200
  • Start Date: April 1, 2020
A Retrospective Chart Review Study to Evaluate Safety of McGhan Single Lumen Gel-Filled Breast Implants in Patients in China
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 86
  • Start Date: December 31, 2019
Special Drug Use Surveillance for Adcetris Intravenous Infusion 50 Milligrams Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Hodgkin Lymphoma (Only Pediatric Patients)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: November 29, 2019
A Open-label, Single-arm Phase Ⅱ Clinical Trial of TQ-B3101 in Subjects With Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL)
View All Clinical Trials